INSIGHTS ON DRUG DEVELOPMENT
-
Quantifying Endotoxins Via Absorbance Or Fluorescence
Find out how endotoxin assays use Factor C activation to generate measurable absorbance or fluorescence signals, with guidance on selecting detection formats and implementing scalable workflows.
-
Utilizing The Colon Intestine-Chip To Investigate Mechanisms Of Gastrointestinal Disease
What are the application and benefits of Organ-Chips and what makes them superior to organoids in the study of GI-related diseases?
-
Exosome Production From hMSC Using A Fixed-Bed Bioreactor
Explore a high-yield, scalable process for hMSC-derived exosome production using fixed-bed bioreactors, with strong performance in purity, recovery, and biological activity.
-
Accelerate FDA Approval With Fast Track Designation
Learn how Fast Track Designation streamlines the FDA review process and offers faster approval for serious diseases or life-threatening conditions.
-
Selecting A CDMO For Custom Activated PEGs1/27/2026
Custom-activated PEGs require thoughtful planning and precise analytical control. Discover key considerations for selecting a partner capable of supporting scalable, compliant PEGylation.
-
EMA Support For Rare Disease Therapies6/10/2025
Review how the EMA supports rare disease drug development through regulatory and financial incentives for therapies that meet strict eligibility and ongoing compliance criteria.
-
How To Solve Complex Pediatric Dosing Challenges Using Tailored Solutions8/11/2025
With a partner who understands the science, the regulations, and the real-world demands of dosing children, development can move faster, smarter, and with greater confidence
-
Glucagon-Like Peptide-1 (GLP-1) Analogues Applications Notebook12/11/2025
View this collection of application notes about the chromatographic analysis and purification of GLP-1 analogues, including Semaglutide, Tirzepatide, Liraglutide, and Exenatide.
-
In Vivo Testing Of Nasal Dosage Forms5/7/2025
Innovative nasal drug delivery strategies can unlock faster, patient-friendly therapeutic solutions by combining smart formulation, advanced testing platforms, and rigorous preclinical evaluation.
DRUG DEVELOPMENT SOLUTIONS
-
STELLARIS STED Microscope
Get faster to the truth
Our STED (stimulated emission depletion) technology joins the STELLARIS platform to provide you the fastest way of imaging beyond the diffraction limit. Obtain cutting-edge nanoscopy results in no time with astounding image quality and resolution, while protecting your sample. STED super-resolution allows you to study multiple dynamic events simultaneously, so you can investigate molecular relationships and mechanisms within the cellular context.
The seamless integration of STED and STELLARIS provides easy access to STED directly from the confocal interface, making it just a few clicks away. Now you can get more insights from your sample, because every detail matters.
-
At Curia, our team of expert protein chemists and structural biologists brings the advanced experience and technology needed to support all your structural biology services needs.
-
The LevMixer™ 10 L single-use mixing system is a low volume mixer designed for both upstream and downstream applications.
-
Learn how strategic filtration safeguards chromatography systems, improves sample quality, and supports efficient protein purification to create smoother, more reliable workflows.
-
Examine ways to accelerate biologic development with high-resolution mass spectrometry services that deliver precise, reliable data from discovery through commercial release.